Glow Lifetech Reports 49% Q/Q Revenue Growth, 73% Gross Margins, and Strengthened Balance Sheet in Q3 2024
Toronto, Ontario--(Newsfile Corp. - December 2, 2024) - Glow LifeTech Corp. (CSE: GLOW) (OTC Pink: GLWLF) (FSE: 9DO) ("Glow" or...
Month: December 2024
A Revolutionary Hybrid Mobility Aid That Puts Independence In Your Hands
Safer than an office chair, smaller than a wheelchair: A mobility aid that adapts to you—seamlessly, without compromising the comfort...
OSSIO Raises $27.6 Million to Accelerate Its Commercial Engine as High Demand for Bio-Integrative Fixation Technology Continues
Proceeds will be used to increase patient access to metal-free OSSIOfiber® surgical implants, which provide a strong fixation solution while...
LevelJump Announces Q3 2024 Financial Results; Provides Update on Cease Trade Order
Toronto, Ontario--(Newsfile Corp. - December 2, 2024) - LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or the "Company"), announced today its financial results...
Bausch Health Appoints New Chief Medical Officer and Head of R&D
LAVAL, QC / ACCESSWIRE / December 2, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is pleased to announce the appointment...
Sunshine Biopharma Announces Breakthrough Research Results on the Company’s K1.1 mRNA Product as a Novel Therapeutic Agent for Human Hepatocellular Carcinoma
FORT LAUDERDALE, FL / ACCESSWIRE / December 2, 2024 / Sunshine Biopharma Inc. (NASDAQ:"SBFM") (the "Company"), a pharmaceutical company offering...
Park Mental Health Treatment Builds an Environment of Trust and Safety to Restore Dignity, Encourage Hope and Promote Healing for Clients
SAN DIEGO, CA / ACCESSWIRE / December 2, 2024 / When it comes to mental health, possessing dignity is critical...
Stereotaxis’ GenesisX Robotic System to be Showcased for the First Time at RSNA 2024 by Neusoft Medical Systems
ST. LOUIS and SHENYANG, China, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS) and Neusoft Medical Systems Co., Ltd...
United Health Products Provides Update on Clinical Study Process
MT. LAUREL, N.J., Dec. 02, 2024 (GLOBE NEWSWIRE) -- United Health Products, Inc. (OTCPK: UEEC) today provided an update on...
Spectral AI Completes Truthing of Burn Center Images, Initiates Emergency Department Image Review
DALLAS, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI)...
Cepham Increases Commitment to Men’s Health With Emphasis on Wellbeing and Plant-Based Ayurvedic Care
SOMERSET, N.J., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Cepham is increasing its commitment to men’s health during the holiday season...
Mapi Pharma is Seeking New Depot Product Partnerships
Management to Participate in 7th Annual Evercore HealthCONx ConferenceNESS ZIONA, Israel, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Mapi Pharma Ltd.,...
Gelteq Announces Largest U.S. Customer Increases Initial Order by 50% to Meet Growing Market Demand
Healthy Extracts expands order after high demand for Gelteq’s collagen and Mynus sugar blocker gelsNEW YORK, Dec. 02, 2024 (GLOBE...
OneMedNet Announces Exciting New Collaboration with Bayer’s AI Innovation Platform to Help Accelerate Healthcare AI Development
MINNEAPOLIS, Dec. 02, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) ("OneMedNet" or the "Company"), a Real-World Data (RWD) platform...
NovelMed Receives FDA IND Approval for NM8074 (Ruxoprubart), the First Anti-Bb Alternative Pathway Blocker for Treating Primary Immunoglobulin A Nephropathy (IgAN): A Renal Disorder
--- The United States FDA Clears Initiation of a Phase II Efficacy Trial in Immunoglobulin A Nephropathy (IgAN) Patients: a...
Canon Medical Informatics Selected by Leading U.S. Health System to Standardize 3D Processing Capabilities in the Cloud Using Vitrea Advanced Visualization Platform
MINNETONKA, Minn., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Canon Medical Informatics, Inc. has been selected by a leading U.S. health...
Psychemedics Corporation Announces Reverse and Forward Stock Split
DALLAS, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Psychemedics Corporation (Nasdaq: PMD) (the “Company”), the world’s leading provider of hair testing...
Polyrizon Enters into GMP Manufacturing Agreement for CTM Supply of its PL-14 Allergy Blocker in Preparation for Planned 2025 Clinical Trial
The engagement with an EU-based GMP manufacturing facility enables timely production and preparation for clinical trial. The EU-based GMP manufacturer...
Ainos, Inc. Announces Strategic Partnership with Taiwan Tanabe Seiyaku to Advance Manufacturing and Taiwan Market Promotion of Sjögren’s Syndrome Drug
San Diego, California--(Newsfile Corp. - December 2, 2024) - Ainos, Inc. (NASDAQ: AIMD) (NASDAQ: AIMDW) ("Ainos" or the "Company"), an...
BioGene Therapeutics Welcomes Stephen Glover to Its Board of Directors
Vancouver, British Columbia--(Newsfile Corp. - December 2, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the...